Literature DB >> 10628941

Gene expression of erythropoietin in renal cell carcinoma.

Y Noguchi1, T Goto, Y Yufu, N Uike, Y Hasegawa, T Fukuda, A Jimi, A Funakoshi.   

Abstract

A 57-year-old man with renal cell carcinoma and erythrocytosis showed a high serum level of erythropoietin (EPO). High EPO signal was observed on Northern blot analysis and RT-PCR in the total RNA extracted from the renal tumor. Immunohistochemical staining also demonstrated tumor tissue with high immunostaining of EPO. Nucleotide sequences of EPO cDNA in the tumor were normal. To date, only one report has discussed the nucleotide sequences of a tumor's EPO gene; it showed mutant EPO cDNA in hepatocellular carcinoma tissue. This is the first demonstration of normal EPO cDNA in renal cell carcinoma.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10628941     DOI: 10.2169/internalmedicine.38.991

Source DB:  PubMed          Journal:  Intern Med        ISSN: 0918-2918            Impact factor:   1.271


  5 in total

1.  Erythrocytosis caused by erythropoietin-producing thymic carcinoma.

Authors:  Wataru Munakata; Kazuteru Ohashi; Koji Sakaguchi; Hirotoshi Horio; Tsunekazu Hishima; Hideki Akiyama; Hisashi Sakamaki
Journal:  Int J Clin Oncol       Date:  2010-02-24       Impact factor: 3.402

2.  Successful treatment of erythropoietin-producing advanced renal cell carcinoma after targeted therapy using sunitinib: Case report and review of the literature.

Authors:  Kosuke Ueda; Shigetaka Suekane; Katsuaki Chikui; Makoto Nakiri; Fukuko Moriya; Tokumasa Hayashi; Jiro Miyajima; Kei Matsuoka
Journal:  Mol Clin Oncol       Date:  2012-08-03

3.  Paraneoplastic hormones: parathyroid hormone-related protein (PTHrP) and erythropoietin (EPO) are related to vascular endothelial growth factor (VEGF) expression in clear cell renal cell carcinoma.

Authors:  Chen-chen Feng; Guan-xiong Ding; Ning-hong Song; Xuan Li; Zhong Wu; Hao-wen Jiang; Qiang Ding
Journal:  Tumour Biol       Date:  2013-06-19

4.  Erythropoietin-producing tubercle granuloma in a hemodialysis patient.

Authors:  Minoru Satoh; Hiroshi Ueta; Takehiko Tokura; Tamaki Sasaki; Naoki Kashihara
Journal:  BMC Nephrol       Date:  2013-04-21       Impact factor: 2.388

Review 5.  Functional significance of erythropoietin in renal cell carcinoma.

Authors:  Christudas Morais; David W Johnson; David A Vesey; Glenda C Gobe
Journal:  BMC Cancer       Date:  2013-01-10       Impact factor: 4.430

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.